Biocon Biologics acquires biosimilars business of Viatris for $3bn

Biocon subsidiary Biocon Biologics has acquired the international biosimilars business of Viatris in a deal totalling $3bn

news

Blacksmith Medicines to merge with Forge Therapeutics

Blacksmith Medicines has signed a definitive merger agreement with Forge Therapeutics to create a combined entity to develop metalloenzyme-targeted drugs

Briefing

Element announces $200 Genome on benchtop sequencing system

Element Biosciences announced that a new throughput-based option for its AVITI System will provide sequencing on a benchtop for $200 a genome

Industry news

Industry briefing

01/19/2023 09:33:23